Company intelligence / Profile preview

China Resources Double-Crane Pharmaceutical

Beijing, Beijing, Chinadcpc.com ↗
Ownership
Private
Employees
~13000
Development stage
Other
01

Overview

CR Double-Crane has a large commercial portfolio with numerous generic and branded pharmaceuticals across chronic disease management (hypertension/blood pressure lowering agents like compound reserpine + triamterene), lipid-lowering agents (pitavastatin), antidiabetics (gliquidone), anti-infectives (levofloxacin mesylate), infusions/nutritional products. The company has recently expanded into new chemical entity development through partnerships such as the exclusive commercialization agreement with Oneness Biotech/Microbio Shanghai for Fespixon® in China. It maintains strong sales growth domestically.

Therapeutic areas
NeurologyMetabolic DisordersPulmonologyInfectious DiseasesEndocrinologyOtherNephrologyCardiovascular
Modalities
Small moleculeBiologic
Industry
Pharma
02

Drug pipeline

10 assets

Beijing 0

4

9 more assets in the full pipeline.

03

Partnerships

Oneness Biotech/Microbio Shanghai – exclusive commercialization of Fespixon® in mainland ChinaNovita Pharmaceuticals – licensing agreement(s)

Beyond the preview

Go deeper on China Resources Double-Crane Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Resources Double-Crane Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call